THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 YTD Q2 P&L / Income Statement

THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-27. View: Segments by Subsegments Consolidation Items. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

22,999,000,000 US dollars

Cost of revenue (calculated)

13,687,000,000 US dollars

Gross profit (calculated)

9,312,000,000 US dollars

Operating expenses (calculated)

5,362,000,000 US dollars

Operating income

3,950,000,000 US dollars

Other income (expense), net (calculated)

negative 292,000,000 US dollars

Income before income taxes

3,658,000,000 US dollars

Benefit from/(provision for) income taxes

238,000,000 US dollars

Net income

3,397,000,000 US dollars

Analytical Instruments

3,563,000,000 US dollars

Life Sciences Solutions

5,450,000,000 US dollars

Undisclosed (calculated)

14,599,000,000 US dollars

Cost of revenues

13,687,000,000 US dollars

Selling, general and administrative expenses

4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Research and development expenses

700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Restructuring and other costs

147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Revenue before reconciliation (calculated)

23,612,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Laboratory Products and Biopharma Services - Intersubsegment Eliminations

negative 468,000,000 US dollars. Reported reconciliation to consolidated revenue.

Specialty Diagnostics - Intersubsegment Eliminations

negative 145,000,000 US dollars. Reported reconciliation to consolidated revenue.

Equity in earnings/(losses) of unconsolidated entities

negative 23,000,000 US dollars. Reported below-tax contribution to net income.

Analytical Instruments costs (calculated)

2,784,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Life Sciences Solutions costs (calculated)

3,456,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Laboratory Products and Biopharma Services - Intersubsegment Eliminations costs (calculated)

11,015,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Specialty Diagnostics - Intersubsegment Eliminations costs (calculated)

1,700,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

94,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M.